@FiercePharma: Biogen takes over marketing JVs that had been selling its MS meds Avonex, Tysabri in 29 countries. Article $BIIB | Follow @FiercePharma
> European regulators approved Novartis' ($NOVN) mTOR inhibitor Afinitor for a rare type of pancreatic cancer on the heels of FDA's nod for the same use. Article
> Pfizer ($PFE) wrapped up its tender offer for Icagen, ending with 54% of the North Carolina-based biopharma, announced a bid of $6 per share to minority shareholders, beginning Sept. 12. News
> San Diego law enforcement officials confirmed a determination of suicide in the death of Medicis Pharmaeutical ($MRX) CEO Jonah Shacknai's girlfriend. Report
> Berlin Pharmaceutical inked a deal to market a range of Swiss-based Acino Pharma's current and future products in Thailand. News
> Drugmaker logos will continue to appear in disclosures of corporate support for continuing education, the Accreditation Council for Continuing Medical Education decided following a mixed reaction to a proposed logo ban. Item
> Eisai is launching two more over-the-counter products in its Selbelle line of stomach drugs. Piece
> Hikma Pharmaceuticals launched its version of the heparin blood thinner in U.S. in single- and multi-use vials. Article
> The British animal health firm Dechra Pharmaeuticals saw increasing sales of branded products lift profits by 15% during the past year. Article
> New Hampshire passes law to allow pharmacists to give vaccines against pneumonia and shingles, as well as seasonal flu. Story
Biotech News
@FierceBiotech: Fierce 15 is now live! See the 15 outstanding private biotechs we've selected this year. Report | Follow @FierceBiotech
@JohnCFierce: One of my favorites is RJ Kirk/Intrexon talking about what he likes in a partner and why he won't work with Big Pharma. Piece | Follow @JohnCFierce
@RyanMFierce: Researchers use neural stem cells (of iPS variety) to study impacts of potential bipolar-disorder treatments. Item | Follow @RyanMFierce
> FDA review drops a bombshell on Bayer, J&J anti-clotting drug Xarelto. More
> Sanofi singles out top pipeline prospects, new cost cuts. News
> Vertex tracks encouraging IIa data for JAK3 rheumatoid arthritis drug. Report
Biotech IT News
> Merck taps Zymeworks' high-tech antibody shop in $187M deal. News
> Facebook app shows how people swap germs. Piece
> Glencoe, Aridhia team to develop life sciences tech. Story
> Impact Corelab sprouts with clinical tech from Radiant Sage. Piece
> Social networking rallies volunteers in Mayo Clinic study. Story
> MedNet seeks funds to compete in EDC game. Item
Manufacturing News
> Abbott exec tapped for H&P manuf. ops. Report
> Lilly looks eastward with generics deal. Article
> Pharma deal-making minimizes manufacturing. Item
> No penalties for stunning gray price hikes on cancer, anesthesia drugs. Story
> GSK sees resistance to wind turbine project. More
> Vax maker CSL on road to GMP compliance. Article
Biotech Research News
> Researchers find new target for PTSD treatment. Read more
> New drug-discovery center lost in translation. Article
> Researchers report promising new TB vaccine. News
> Stem cells open new front against bipolar disorder. More
> Pimple treatments pocked with poor supporting science. Item
> Get fat stem cells talking to follicles and up sprouts hair. Story
And Finally... Menopause may not be the culprit in women's increasing heart risks. Report